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Abstract 
Neuronal dendritic and synaptic pruning are early features of neurodegenerative diseases, including Alzheimer’s disease. 
In addition to brain pathology, amyloid plaque deposition, microglial activation, and cell loss occur in the retinas of 
human patients and animal models of Alzheimer’s disease. Retinal ganglion cells, the output neurons of the retina, are 
vulnerable to damage in neurodegenerative diseases and are a potential opportunity for non-invasive clinical diagnosis 
and monitoring of Alzheimer’s progression. However, the extent of retinal involvement in Alzheimer’s models and how 
well this reflects brain pathology is unclear. Here we have quantified changes in retinal ganglion cells dendritic structure 
and hippocampal dendritic spines in three well-studied Alzheimer’s mouse models, Tg2576, 3xTg-AD and  APPNL-G-F. 
Dendritic complexity of DiOlistically labelled retinal ganglion cells from retinal explants was reduced in all three models 
in an age-, gender-, and receptive field-dependent manner. DiOlistically labelled hippocampal slices showed spine loss 
in CA1 apical dendrites in all three Alzheimer’s models, mirroring the early stages of neurodegeneration as seen in the 
retina. Morphological classification showed that loss of thin spines predominated in all. The demonstration that retinal 
ganglion cells dendritic field reduction occurs in parallel with hippocampal dendritic spine loss in all three Alzheimer’s 
models provide compelling support for the use of retinal neurodegeneration. As retinal dendritic changes are within the 
optical range of current clinical imaging systems (for example optical coherence tomography), our study makes a case 
for imaging the retina as a non-invasive way to diagnose disease and monitor progression in Alzheimer’s disease.
Keywords: Alzheimer’s disease, Retinal ganglion cells, Dendritic spines, DiOlistic labelling, Sholl analysis, Synaptic 
pruning
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco 
mmons .org/publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Introduction
Alzheimer’s disease (AD) is the underlying cause of up to 
70% of all dementias and estimated to afflict 40 million 
people worldwide by 2050 [32, 36]. AD pathology is char-
acterised by extracellular amyloid plaques, neurofibril-
lary tangles, neuroinflammation and synaptic loss that 
ultimately result in severe brain atrophy [14, 37, 42, 49]. 
Synaptic dysfunction is the strongest correlator to AD 
severity and a target for therapeutic intervention [49, 51]. 
Currently, the detection of early neurodegeneration is 
challenging and relies on insights from AD animal mod-
els that recapitulate aspects of the disease.
Visual impairment has been reported as an early symp-
tom in some individuals diagnosed with neurodegen-
erative disease, including AD [11, 25]. Visual deficits 
can include reduced acuity, visual field defects, changes 
in contrast sensitivity, impaired object recognition, and 
delayed visual processing [30]. While of interest, these 
observations have not pinpointed specific deficits in the 
visual pathway that consistently account for a reduction 
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in visual performance. However, retinal changes have 
received little attention. The retina has been proposed 
as a surrogate for in vivo detection and monitoring AD-
related changes in the central nervous system (CNS) 
since the retina can be considered an extension of the 
brain and is accessible for imaging [28, 29, 38]. AD reti-
nal pathology resembles that found in the brain, includ-
ing neuronal cell loss, particularly of retinal ganglion cells 
(RGCs) [8]. However, loss of RGCs, the output neuron 
of the retina, and resulting thinning of the retinal nerve 
fibre layer (RGC axons) suggests that these could be a 
meaningful index of cognitive decline and a feature in 
AD [31, 45].
RGCs may be particularly susceptible to damage in 
the context of AD because of their intraocular unmyeli-
nated axons, high energy demand and complex dendritic 
arbours [20]. The morphology of the RGC dendritic field 
and the disruption of glutamatergic synapses along the 
dendrites associate with neuronal function and dendritic 
degeneration correlates with visual decline [33]. RGC 
dendritic pruning is characterised by the loss of dendritic 
complexity and is a feature in retinal neurodegeneration 
models [52, 55]. The underlying mechanism of dendritic 
loss is unclear; however, it is an important characteristic 
in the early stages of neurodegeneration. We have pre-
viously reported that RGC dendritic degeneration is an 
early pathological event in the Tg2576 AD mouse model 
compared to littermate wildtype controls [54]. However, 
it is not known whether these findings are reproducible 
across other AD mouse models, are present at different 
time points in disease pathogenesis, and, whether RGC 
dendritic loss correlates with degenerative events in the 
CNS in the models.
To address these issues, we characterised the RGC den-
dritic morphology in amyloid overexpressing (Tg2576, 
3xTg-AD) and knock-in  (APPNL-G-F) AD mouse models. 
Using DiOlistic labelling, a technique that is not contin-
gent on cell health, RGCs were morphologically assessed 
and compared to the dendritic spine densities in the hip-
pocampus in the same mice [18, 41, 52]. Our findings 
demonstrate consistent and progressive RGC degeneration 
from early in the disease process in both overexpressing 
and knock-in AD models. Retinal changes also correlated 
with a reduction in hippocampal spine densities in each of 
the models. The findings support the assessment of retinal 
changes to detect early-stage neurodegeneration and mon-
itor disease progression in models and man.
Methods
Animals
All animal experiments complied with the UK Ani-
mals Scientific Procedures Act 1986 and ethical guide-
lines at Cardiff University. Experiments were carried 
out under the authority of UK Home Office licences 
30/3220, P8159A562 and 30/03313. Mice were group-
housed where possible in environmentally enriched 
cages with food and water ad  libitum in a 12-h light/
dark cycle. Tg2576 (In-house line, (strain: B6; SJL-
Tg(APPSWE)2576Kha), 3xTg-AD (The Jackson Lab-
oratory, (strain 34830-JAX: B6; 129-Tg(APPSwe, 
tauP301L)1Lfa  Psen1tm1Mpm/Mmjax)) and  APPNL-G-F 
(RIKEN, Japan) (strain:  Apptm3.1Tcs/Apptm3.1Tcs)) mouse 
models were analysed with Tg2576 compared to wildtype 
littermate controls (WT Control) and the 3xTg-AD and 
 APPNL-G-F models compared to C57BL/6J (B6/J Control, 
in house colony). It was not possible to compare 3xTg-
AD and  APPNL-G-F mice to littermate controls; instead, 
we compared our observations to C57BL6/J mice (B6/J 
Controls) since the  APPNL-G-F model are based on the 
same background. Littermate controls for the 3xTg-AD 
model are not available due to the mixed background 
and shotgun approach used to generate this model. 
The Jackson Laboratory offer an approximate control 
(B6129SF2/J, Stock No: 101045) for the 3xTg-AD strain, 
however, this strain is known to develop other confound-
ing features. Both sexes were analysed for B6/J Control, 
3xTg-AD and  APPNL-G-F; however, only males were avail-
able for the Tg2576 model. Table  1 provides details on 
the number of mice, RGCs and hippocampal dendritic 
segments analysed from each model at 6–7 months and 
12 months. The specific number of mice, RGCs and hip-
pocampal dendritic segments are included where appro-
priate with the associated figures.
Tissue harvest
For retinal analysis, eyes were enucleated and transferred 
to chilled 4  °C HBSS (Hank’s Balanced Salt Solution), 
punctured with a needle at the limbus and the cornea, 
lens, vitreous and sclera removed. Retinal explants were 
flat-mounted ganglion cell layer up. For hippocampal 
analysis, whole brains were removed and cut sagittally 
in chilled 4  °C HBSS. In one hemisphere, parasagittal 
hippocampal regions were sliced (200 µm) in a septal to 
temporal progression using a McIlwain tissue chopper. 
The total time for retinal explant preparation from both 
eyes and hippocampal slicing in a single mouse was less 
than 10 min, since time is critical for DiOlistic labelling 
efficiency.
DiOlistic preparation and neuronal labelling
Fresh retinal explants and hippocampal slices prepared 
as above were transferred to glass slides and subjected to 
gene gun (BioRad) DiOlistic labelling of neurons [10, 47, 
50]. In brief, Ethylene tetrafluoroethylene (ETFE) tubing 
was coated with 1.67 µm tungsten particles coated with 
1,1′-Dioctadecyl-3,3,3′,3′-Tetramethylindocarbocyanine 
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Perchlorate (DiI, Life Technologies) and 3,3′Dioctade-
cloxacarbocyanine Perchlorate (DiO, Life Technologies). 
Dye coated ETFE ‘bullets’ were cut at 1.2  cm, loaded 
into the gene gun and fired onto the slides at a pressure 
of 100–120 psi through a 3.0 µm membrane (BD Falcon 
3.0  µm, BD Biosciences). Slides were then immersed in 
Neurobasal-A medium (Life Technologies) for 20  min 
at 37  °C with 5%  CO2. Dye staining was checked under 
a fluorescence microscope to confirm neuron labelling 
then slides were fixed in 4% PFA (paraformaldehyde) for 
a minimum of 30  min, with subsequent nuclei labelling 
with Hoechst 33258. Slides were coverslipped with Fluor-
Save and stored in the dark at 4 °C until analysis.
Confocal imaging
All confocal images were captured using a Leica SP8 
Lightning confocal microscope. RGCs were identified by 
their morphology and relative position in the retina, i.e. 
in the ganglion cell layer, characteristic dendritic field and 
a clear axon projecting towards the optic nerve. RGCs 
with overlapping dendritic fields that prevented single-
cell delineation were excluded from the analysis. Den-
dritic arbours were imaged using 20 × objective (z-axis, 
interval 1 µm). Hippocampal dendrites (CA1 field) were 
selected based on the minimal overlap of adjacent cells. 
CA1 apical dendritic spines were imaged at 63 × objec-
tive (z-axis, interval 0.2  µm) using Lightning Deconvo-
lution (Leica). Typically, each hippocampal slice yielded 
at least one CA1 neuron suitable for imaging; 10–15 
images/neurons were imaged per mouse.
Neuronal reconstruction
All confocal images were analysed using Imaris soft-
ware (version 9.2, Bitplane, Zurich, Switzerland). RGC 
dendritic fields and hippocampal dendrites were recon-
structed using the Filament Tracer module with default 
thresholding based around a ‘region of interest,’ i.e. the 
dendritic field. All dendritic arbours were automatically 
traced within the software with any incorrect tracing, 
e.g. adjacent cells or dye debris manually removed. The 
associated statistical parameters were exported from 
Imaris for data analysis with Sholl analysis used for 
a measure of dendritic complexity (at set intervals of 
10  µm). Dendritic spines were reconstructed using the 
Filament tracer in the same process as retinal ganglion 
cells; however smaller ‘regions of interest’, i.e. dendritic 
segments typically of 30 µm were analysed. Spines were 
detected using the Filament Tracer module and classi-
fied using the SpineClassifer MATLAB extension. Spine 
types were distinguished on the basis of spine length 
and spine head size.
Retinal ganglion cell receptive field classification
Retinal ganglion cells were classified based on their den-
dritic lamination into the inner plexiform layer [1, 53]. 
Dendrites projecting into the sublamina b (closest to the 
ganglion cell layer) were termed ON-centre; conversely, 
dendrites projecting into the sublamina a were termed 
OFF-centre [56].
Nuclei counts
The number of nuclei in the ganglion cell layer were 
quantified from Hoechst labelling from the DiOlistic 
RGC confocal images. All RGC images with Hoechst 
33258 labelling were quantified using the Spots function 
in Imaris and averaged to obtain a nuclei ganglion cell 
layer count per animal. Parameters were kept consistent 
for all quantifications.
Statistics
Data are represented as individually reconstructed reti-
nal ganglion cells and dendritic segments for spine den-
sities collected for each group. Statistical analyses were 
performed using GraphPad Prism software (version 8) 
with the statistical tests and details of data reported in 
each figure legend where appropriate. Data were analysed 
Table 1 Number of mice, RGCs and hippocampal dendritic segments across all models analysed
WT wildtype, RGCs retinal ganglion cells
Model Age analysed: 6–7 months Age analysed: 12 months
Mice (n) RGCs (n) Hippocampal dendritic 
segments (n)
Mice (n) RGCs (n) Hippocampal 
dendritic segments 
(n)
WT Control X X X 7 74 71
Tg2576 X X X 8 58 85
B6/J Control 6 58 47 10 114 106
3xTg-AD 9 99 77 12 144 223
APPNL-G-F 7 94 46 6 80 130
Total 22 251 170 43 470 615
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using the Mann–Whitney U test, 1-way analysis of vari-
ance (Kruskal–Wallis test) using Dunn multiple com-
parisons post-test or two-way ANOVA, as appropriate. 
Associations between pathological variables were tested 
by Spearman analysis. Significant results are denoted 
as follows: * = p < 0.05, ** = p < 0.01, *** = p < 0.001, 
**** = p < 0.0001.
Results
Retinal ganglion cell degeneration is a common feature 
of the Tg2576, 3xTg‑AD and  APPNL‑G‑F AD mouse models
We first sought to determine whether RGC den-
dritic degeneration occurred in Tg2576, 3xTg-AD and 
 APPNL-G-F AD mouse models at 12 months, a time point 
when these models have been demonstrated to have hip-
pocampal and behavioural degenerative changes that are 
indicative of AD-like pathology. Sholl analysis demon-
strated significant reductions in dendritic complexity in 
all three AD models compared to respective age-matched 
wildtype control mice (littermate controls for Tg2576 
mice and B6/J controls for 3xTg-AD and  APPNL-G-F mice) 
(Fig.  1a–e). Sub-analysis, according to dendrite branch 
hierarchy, showed preservation of primary dendrites 
across the three AD models. However, 3xTg-AD RGCs 
showed significant secondary dendritic loss, and all mod-
els showed tertiary and quaternary dendritic pruning 
(Fig. 1f ). Overall the area under the Sholl curve (AUC; a 
global measure of dendritic complexity) showed signifi-
cant pruning in all three AD models, with the greatest 
dendritic loss observed in the  APPNL-G-F retina (Fig. 1g). 
These reductions were matched by a decrease in the peak 
of the Sholl curve and the total dendrite length (Fig. 1h–
i). Notably, the dendritic changes occurred in the absence 
of significant cell loss in the ganglion cell layer (GCL, 
Fig.  1j). We also observed dendritic varicosities (swell-
ing of the dendrites) which coincided with an increased 
diameter of the dendrites situated around and after the 
peak of the Sholl curve (branching levels 4–7) in RGCs 
from all AD model mice (Fig. 2).
We were able to assess RGC dendritic structure in 
6–7-month and 12 month 3xTg-AD,  APPNL-G-F and B6/J 
Control mice (Fig. 3). In 3xTg-AD mice at 6–7 months, 
RGCs showed no excess dendritic pruning compared 
to B6/J Control; however, at 12  months 3xTg-AD mice 
demonstrated significantly greater dendritic loss com-
pared to controls (Fig. 3a, b). In comparison to B6/J Con-
trol,  APPNL-G-F mice at 6–7 months showed significantly 
greater RGC dendritic degeneration with a reduced Sholl 
profile corresponding to the highest branched areas of 
the dendritic field; comparison with  APPNL-G-F mice at 
12 months showed significantly increased dendritic loss 
with age (Fig. 3c, d). In B6/J Control mice, RGC dendritic 
complexity was not different between 6-7  months and 
12 months (Fig. 3e). These findings were also supported 
by quantitative assessments of the Sholl AUC, the peak 
of the Sholl intersections, and the total dendritic length 
(Fig. 3f–h) which demonstrate that increased RGC den-
dritic atrophy occurs in AD model mice and progres-
sively worsens with age.
ON‑centre specific RGCs are more affected in the AD model 
mouse retina
We next investigated whether RGCs changes were influ-
enced by RGC type. RGCs with dendritic lamination in 
inner plexiform layer (IPL) sublamina b are classified as 
ON-centre and those with dendrites in sublamina a are 
classified as OFF-centre. RGCs were compared across 
all three AD models at 12  months (Fig.  4). Significant 
ON-centre RGC dendritic loss was present in all three 
AD models (Fig. 4a–e).  APPNL-G-F and, to a lesser degree 
3xTg-AD mice demonstrated significant dendritic loss 
compared to controls in OFF-centre RGCs; a non-signif-
icant trend of increased dendritic loss in the OFF-centre 
RGCs was seen in Tg2576 mice compared to controls 
(Fig. 4f–j). Collectively, these data show a greater suscep-
tibility for ON-centre RGC degeneration across the three 
AD models.
Retinal ganglion cell dendritic impairment is more 
prominent in male AD mice
Since gender-related differences in susceptibility have 
been reported in AD models, we next determined 
whether this was a factor influencing the degree of RGC 
dendritic pruning in the 3xTg-AD and  APPNL-G-F models 
where sufficient mice of both genders were available for 
analysis. Both male and female 3xTg-AD and  APPNL-G-F 
models demonstrated significant RGC dendritic loss 
compared to gender-matched B6/J Control (Fig.  5a–i). 
There were no morphological differences in RGCs 
between male and female B6/J Control mice (Fig. 5g). In 
contrast, we observed increased degeneration in RGCs 
from male compared to female mice in both the 3xTg-AD 
and  APPNL-G-F models, the former exhibiting the largest 
difference between genders (Fig.  5h, i). These findings 
were supported by quantitative measures of the Sholl 
AUC (Fig. 5j), the peak of the Sholl curve (Fig. 5k), and 
total dendrite length (Fig. 5l).
Retinal pathology reflects hippocampal dendritic spine 
loss in the AD models
To determine the relationship between retinal and CNS 
(hippocampal) neurodegeneration, we measured, in 
the same mice, dendritic spines in the hippocampus 
of Tg2576, 3xTg-AD and  APPNL-G-F mice at 12  months 
(Fig.  6a). All three AD models displayed overall reduc-
tions in spine density on CA1 hippocampal neurons 
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compared to respective wildtype controls, with 3xTg-
AD mice the most severely affected (Fig.  6b). Dendritic 
spines can be subdivided based on morphological differ-
ences that reflect the functional diversity of the synapses 
[39]. Classifying the dendritic spines based on morphol-
ogy revealed differences between the models. Thin spines 
showed a significant reduction in all models, while only 
3xTg-AD mice demonstrated a significant reduction 
in the number of stubby spines, and mushroom spines 
were unaffected across all models (Fig.  6c–e). Loss of 
spines, significantly correlated with RGC dendritic loss 
in the 3xTg-AD and  APPNL-G-F mice when separated 
on morphology, thin spines showed the best correla-
tion (Fig.  6f–g). We also analysed CA1 spine densities 
Fig. 1 RGC dendritic loss at 12 months in Tg2576, 3xTg-AD and  APPNL-G-F mice. a Representative confocal images of RGCs from WT Control, 
Tg2576, B6/J Control, 3xTg-AD and  APPNL-G-F. Arrows indicate axon. Scale bar 100 µm. b Corresponding dendritic field reconstructed in Imaris. c–f 
Sholl analysis of all reconstructed RGCs comparing single models to show significance. Line represents mean of group at each interval, shaded 
error zones represent ± SEM. Two-tailed Mann–Whitney U test at each interval distance, *p < 0.05, g number of dendrites at each branching level 
proximal to the cell body. Error bars correspond to SD. h Area under the Sholl curve. i Maximum number of Sholl intersections. j Total length of 
all dendrites. k Number of Hoechst-positive nuclei in the GCL. Column Scatterplots g bars represent mean from individual cells and error bars 
correspond to SD. Column Scatterplots h–j data points represent individual cells and error bars correspond to SD. Column Scatter plot k data points 
represent individual mice and error bars correspond to SD. WT Control: n = 74 cells (7 male mice), Tg2576: n = 58 cells (8 male mice), B6J Control: 
n = 114 cells (10 mice, 5 male/5 female), 3xTg-AD: n = 144 cells (12 mice, 6 male/6 female) and  APPNL-G-F: n = 80 cells (6 mice, 3 male/3 female). 
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. All mice aged 12 months. WT wildtype, AUC area under the Sholl curve, GCL ganglion cell layer
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in B6/J Control, 3xTg-AD and  APPNL-G-F mice between 
the ages of 6–7  months (Fig.  6h–k). At this age, overall 
spine density was only reduced in  APPNL-G-F mice; again 
thin spines were the most affected. In the 3xTg-AD mice, 
despite no apparent overall spine reduction, the number 
of stubby spines was significantly decreased whilst the 
density of mushroom spines was increased compared to 
B6/J Controls. These data demonstrate that hippocampal 
spine loss is a consistent feature in all models and corre-
lates with RGC changes.
Discussion
Dendritic and spine loss are among the earliest events 
in neurodegeneration. While regions such as the hip-
pocampus and cortex, are primary sites of pathology 
in AD, other parts of the CNS, including the retina, are 
affected [15, 26]. AD-relevant changes in the retina in 
AD models and human disease offer the prospect of non-
invasive monitoring through in  vivo imaging of retinal 
pathology as a tool to diagnose disease, monitor progres-
sion and test the efficacy of AD treatments; however, to 
date, reports of retinal pathology in humans and animal 
models have been few and inconsistent [5]. Justino et al. 
[22] suggested no retinal dysfunction based on  nor-
mal scotopic and photopic flash electroretinograms 
(fERGs) and oscillatory potentials (OPs) in AD cases. 
While others report the absence of amyloid deposits and 
tau pathology in the retinas of post mortem AD cases, 
despite the detection in the brain [16]. In the retina of 
APP/PS1 mice, Chidlow et  al. [5] found no relevant 
retinal pathology despite the presence of robust brain 
amyloid pathology, however in the same model Koronyo-
Hamaoui et al. [23] report the in vivo detection of amy-
loid plaques in the retina that accumulated with disease 
progression. We have previously reported a preliminary 
study that documented reduced RGC dendritic complex-
ity in the Tg2576 AD mouse model [54]; RGC dendritic 
integrity was reduced at 14 months. Here we have con-
firmed and extended these findings; we found significant 
RGC dendritic loss in Tg2576 mice compared with age-
matched littermate controls at 12 months that occurred 
alongside observed hippocampal spine loss in the same 
animals.
In order to explore whether this observation could 
be general in nature, we next examined retinal and hip-
pocampal pathology in two other mouse AD models, 
the widely used 3xTg-AD model (transgenic expression 
of three risk genes; APP Swedish, MAPT P301L, and 
PSEN1 M146V) and the recently described  APPNL-G-F 
model (knock-in of a humanized Aβ region including the 
Swedish “NL”, the Iberian “F”, and the Arctic “G” muta-
tions). It was not possible to compare 3xTg-AD mice to 
littermate controls because of the complex background 
of this strain as has been noted by The Jackson Labo-
ratory  (https ://www.jax.org/strai n/10104 5), therefore 
we pragmatically chose to use C57BL6/J mice (B6/J) as 
controls. Animal breeding constraints prevented the 
use of littermate controls for the  APPNL-G-F mice; these 
are on the B6/J background so B6/J mice were used as 
controls. We selected DiOlistic labelling as a technique 
for measurement of dendritic complexity because the 
DiOlistic labelling of individual cells is not contingent on 
the health of the cell [19]. Using other methods such as 
the expression of fluorescent proteins can be problem-
atic in chronic disease models since healthier neurons 
may show higher levels of expression, reducing sensitivity 
for detecting degenerating neurons. We have previously 
reported this effect when comparing degeneration in ret-
inal ganglion cells labelled with YFP compared with DiI 
in a chronic murine glaucoma model [52]. Using multiple 
morphological parameters, we observed significant RGC 
dendritic loss compared to B6/J controls at 12  months 
in the 3xTg-AD and  APPNL-G-F models, with the greatest 
severity seen in the  APPNL-G-F mice. At 6–7 months there 
was no significant loss of RGC dendrites in the 3xTg-AD 
Fig. 2 RGC dendritic diameter increases in AD mice. a Representative 
confocal images of RGC dendrites from WT Control, Tg2576, B6J 
Control 3xTg-AD and  APPNL-G-F. Arrows indicate beading and swelling 
of dendrites. Scale bar 25 µm. b Dendrite varicosity, assessed by 
measurement of dendrite diameter. Column Scatterplots: data 
points represent individual cells and error bars correspond to SD. 
WT Control: n = 74 cells (7 male mice), Tg2576: n = 58 cells (8 male 
mice), B6J Control: n = 114 cells (10 mice, 5 male/5 female), 3xTg-AD: 
n = 144 cells (12 mice, 6 male/6 female) and  APPNL-G-F: n = 80 cells (6 
mice, 3 male/3 female). All mice aged 12 months. *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001
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mice; in contrast,  APPNL-G-F mice showed significant 
RGC dendritic loss even at this early age, though not to 
the extent seen at 12  months in this model, confirming 
disease progression with age in both models. The identifi-
cation of RGC dendritic loss may be reflected in a reduc-
tion in the thickness of the retinal layers. Although we 
did not measure this, others have reported that 3xTg-AD 
mice display thinning of the retinal sublayers, including 
the GCL and IPL, which correlate with changes occur-
ring the brain [7]. We also observed significant swelling 
and beading of the dendrites in the RGCs from AD mod-
els, possibly indicating mitochondrial dysfunction [12]. 
Of note, there was no significant reduction in number of 
nuclei in the ganglion cell layer implying that the number 
of RGC’s were unaffected. In all three models, RGC den-
dritic loss occurred in parallel with hippocampal den-
dritic spine loss; these correlated strongly in the 3xTg-AD 
and  APPNL-G-F mice.
We next determined whether there was any selectivity 
for specific RGC subtypes in dendritic loss. RGCs can be 
categorised as ON-centre or OFF-centre, based on their 
response to illumination; these can be distinguished mor-
phologically, ON-centre RGC dendrites projecting into 
sublamina b while OFF-centre RGC dendrites project 
into sublamina a [56]. In all three models, the loss of den-
drites in ON-centred RGCs was more pronounced than 
in OFF-centre RGCs; ON-centre RGCs are depolarised 
by illumination. Their selective loss in the models may be 
Fig. 3 RGC dendritic loss progresses with age in 3xTg-AD and  APPNL-G-F mice. a–e Sholl analysis of all reconstructed RGCs from B6J Control, 3xTg-AD 
and  APPNL-G-F at 6–7 and 12 months comparing single models to show significance. Line represents mean of group at each interval, shaded error 
zones represent ± SEM. Two-tailed Mann–Whitney U test at each interval distance, *p < 0.05. f Area under the Sholl curve. g Maximum number of 
Sholl intersections. h Total length of all dendrites. Column Scatterplots f–h data points represent individual cells and error bars correspond to SD. 
B6J Control 6–7 M: n = 58 cells (6 mice, 6 male), B6/J Control 12 M: n = 114 cells (10 mice, 5 male/5 female), 3xTg-AD 6–7 M: n = 99 cells (9 mice, 9 
male), 3xTg-AD 12 M: n = 144 cells (12 mice, 6 male/6 female),  APPNL-G-F 6–7 M: n = 94 cells (7 mice, 4 male/3 female mice) and  APPNL-G-F 12 M: n = 80 
cells (6 mice, 3 male/3 female). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. WT wildtype, AUC area under the Sholl curve
(See figure on next page.)
Fig. 4 RGC receptive field classification impacts on dendritic loss. a–b Representative confocal images of ON-centre RGCs from WT Control, 
Tg2576, B6J Control 3xTg-AD and  APPNL-G-F with corresponding Imaris reconstructions. Arrows indicate axons. Scale bar 100 µm. c–e Sholl analysis of 
reconstructed ON-centre RGCs comparing single models to show significance. Two-tailed Mann–Whitney U test at each interval distance, *p < 0.05. 
f–g Representative confocal images of OFF-centre RGCs from WT Control, Tg2576, B6J Control, 3xTg-AD and  APPNL-G-F with corresponding Imaris 
reconstructions. Arrows indicate axons. Scale bar 100 µm. h–j Sholl analysis of reconstructed OFF-centre RGCs comparing single models to show 
significance. Two-tailed Mann–Whitney U test at each interval distance, *p < 0.05. Sholl analysis line represents mean of group at each interval, 
shaded error zones represent ± SEM. WT Control ON: n = 43 cells, WT Control OFF: n = 31 cells (7 male mice) Tg2576 ON: n = 30 cells, Tg2576 OFF: 
n = 28 cells (8 male mice); B6/J Control ON: n = 56 cells, B6/J Control OFF: n = 58 cells (10 mice, 5 male/5 female); 3xTg-AD ON: n = 69 cells, 3xTg-AD 
OFF: n = 75 cells (12 mice, 6 male/6 female);  APPNL-G-F ON: n = 38 cells,  APPNL-G-F OFF: n = 41 cells (6 mice, 3 male/3 female). All mice aged 12 months. 
WT wildtype
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a consequence of their higher energy demand and higher 
number of excitatory glutamatergic synapses [53].
Loss of hippocampal dendritic spines is a key hallmark 
of many AD models with spine loss particularly acute in 
the vicinity of amyloid plaques [46]. Dendritic spines can 
be subdivided into mushroom, stubby and thin catego-
ries based on morphology; [3] these morphological dif-
ferences reflect functional diversity [39]. Thin spines are 
highly dynamic, capable of activity-dependent formation 
of new synapses during the process of learning. Loss of 
thin spines is associated with deficits in spatial learning 
and memory and has been reported in a range of CNS 
regions and contexts, such as the prefrontal cortex and 
hippocampus during normal ageing [57]. We used the 
SpineClassifier function in Imaris to label spine types on 
the basis of spine length and head size and re-analysed 
the hippocampal spine loss data. In each of the three AD 
models we observed a clear selective effect, a significant 
loss of thin spines with preservation of mushroom and 
stubby spines. Thin spine loss was particularly strongly 
correlated with the extent of RGC dendritic atrophy 
in the 3xTg-AD and  APPNL-G-F mice when compared 
with B6/J Controls. These findings reinforce the critical 
importance of dendritic spine loss as part of AD pathol-
ogy; the observed thin spine selectivity fits with deficits 
in learning and memory in the models and in AD. Our 
results are supported by other studies that report den-
dritic spine loss, particularly in the hippocampus, of 
AD models [4, 35, 58]. The strong correlation with RGC 
degeneration indicates that retinal measures can provide 
an index of synaptic status in the hippocampus during 
AD pathology.
Gender variation in the 3xTg-AD model has been 
reported in the literature with more consistent pathology 
found in females [2]. We were able to separately measure 
RGC dendritic degeneration in male and female 3xTg-
AD and  APPNL-G-F mice at 12 months; surprisingly, RGC 
dendritic loss was more pronounced in males in both 
models, more obviously in the 3xTg-AD  model. Previ-
ous studies have reported other retinal pathologies in 
the 3xTg-AD model, including amyloid plaques, inflam-
mation and microglial activation that could contribute 
to the observed RGC dendritic changes and gender dif-
ferences in this model [13, 40]. The reason for these gen-
der-dependent effects on RGC degeneration are unclear; 
however, given the known role of complement in synaptic 
loss in AD models [17, 43, 44, 55] and in synapse elimina-
tion in the CNS [48] we suggest that a possible driver of 
observed gender differences relate to differences in com-
plement activity. Numerous studies have demonstrated 
gender differences in complement activity across mouse 
strains with male mice consistently showing more com-
plement activity that females [24]; this would translate 
into more efficient complement activation at the synapse 
and greater synapse loss in male mice. Our (unpublished) 
analyses of the impact of complement gene deletion on 
synaptic loss in mouse AD models support this sugges-
tion. Our study demonstrates the occurrence of RGC 
degeneration as an early and well-correlated marker of 
hippocampal neurodegeneration in both overexpressing 
and knock-in mouse models of AD. These findings pro-
vide vital evidence of significant retinal pathology in AD 
mouse models and reinforces the potential of monitoring 
disease by imaging the retina in human neurodegenera-
tive diseases. There are limitations in extrapolating from 
models to human disease; hence it is possible that some 
of the reported retinal changes may not be reflected in 
the human disease [6]. Our demonstration that RGC 
dendritic degeneration occurs in the retina of knock-in 
 APPNL-G-F mice, the best available model for amyloido-
sis in the human disease because it does not suffer from 
overexpression artefacts, supports relevance. RGCs from 
 APPNL-G-F mice progressively degenerated with age and 
showed signs of dendritic changes early in the disease 
course that correlated with hippocampal changes and 
were in line with the known disease progression in the 
model.
Our data support the development of clinical imag-
ing strategies targeting the inner plexiform layer (IPL), 
the region where RGC dendrites are located, to pro-
vide a non-invasive diagnostic tool and correlate of 
synaptic degeneration in the CNS in AD. RGC degen-
eration in the IPL can be imaged in vivo at high reso-
lution using optical coherence tomography (OCT). 
Fig. 5 Gender influences the extent of RGC dendritic impairment at 12 months in the 3xTg-AD and  APPNL-G-F mice. a–i Sholl analysis of 
reconstructed RGCs from male and female mice compared to B6/J Control and within each model. a represents all the male data, d represents all 
the female data, b–c, and e–i compare single models to show significance. Two-tailed Mann–Whitney U test at each interval distance, *p < 0.05. 
Sholl analysis line represents mean of group at each interval, shaded error zones represent ± SEM. j Area under the Sholl curve. Two-way ANOVA: 
Interaction: F (2, 332) = 3.629, p = 0.0276; Genotype: F (2, 332) = 42.38, p < 0.0001; Gender: F (1, 332) = 5.701, p = 0.0175. k Maximum number of 
Sholl intersections. Two-way ANOVA: Interaction: F (2, 332) = 2.490, p = 0.0845; Genotype: F (2, 332) = 32.72, p < 0.0001; Gender: F (1, 332) = 4.182, 
p = 0.0416. l Total length of all dendrites. Two-way ANOVA: Interaction: F (2, 332) = 3.213, p = 0.0415; Genotype: F (2, 332) = 47.40, p < 0.0001; Gender: 
F (1, 332) = 6.137, p = 0.0137. Column Scatterplot j–l data points represent individual cells and error bars correspond to SD. B6J Control male: n = 64 
cells (5 mice), B6J Control female: n = 50 cells (5 mice); 3xTg-AD male: n = 69 cells (6 mice), 3xTg-AD female: n = 75 cells (6 mice);  APPNL-G-F male: 
n = 45 cells (3 mice),  APPNL-G-F female: n = 35 cells (3 mice). All mice aged 12 months. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. AUC area 
under the Sholl curve
(See figure on next page.)
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With the development of broad-spectrum light sources, 
OCT can detect changes in the optical scattering char-
acteristic of neurons undergoing degeneration and 
even changes in neuronal membrane refractive index 
that correlate with neuronal activity [21, 27, 34]. The 
demonstration that retinal changes occur in both the 
3xTg-AD and  APPNL-G-F AD models early in the dis-
ease process and correlate with synaptic dysfunction, 
an early pathological event preceding neuronal cell loss 
and amyloid deposition in AD [9], indicates that retinal 
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imaging has the potential to provide insights into the 
CNS health in mild cognitive impairment and the early 
stages of AD.
Abbreviations
AD: Alzheimer’s disease; CNS: Central nervous system; RGCs: Retinal ganglion 
cells; IPL: Inner plexiform layer; OCT: Optical coherence tomography; GCL: 
Ganglion cell layer.
Acknowledgements
The authors would like to thank Anthony Hayes and Mark Isaacs at Bioimaging 
Research Hub at Cardiff School of Biosciences for assistance and use of Imaris 
funded by Cardiff University’s Research Infrastructure Fund.
Authors’ contribution
All authors contributed to the study conception and design. Material prepara-
tion, data collection and analysis were performed by RJB. Assistance with ani-
mals was provided by TRH and MAG. The manuscript was written by RJB, PAW, 
BPM and JEM are all authors who read and approved the final manuscript.
Fig. 6 Hippocampal dendritic spine loss correlates with RGC dendritic changes in Tg2576, 3xTg-AD and  APPNL-G-F mice. a Representative confocal 
images of DiI labelled dendritic segments of CA1 segments from WT Control, Tg2576, B6J Control, 3xTg-AD and  APPNL-G-F. Scale bar 5 µm. Spine 
densities were analysed from dendritic segments of at least 30 µm b Overall spine density. c Stubby spine density. d Mushroom spine density. e 
Thin spine density. f Total number of dendritic spines compared to RGC AUC per mouse for 3xTg-AD and  APPNL-G-F models (Spearman correlation). 
g Total number of thin dendritic spines compare to RGC AUC per mouse for 3xTg-AD and  APPNL-G-F models (Spearman correlation). Data 
represented as average per mouse. g Column Scatterplot data points represent individual cells and error bars correspond to SD. Overall (h), stubby 
(i), mushroom (j) and thin (k) spine density from B6/J Control, 3xTg-AD and  APPNL-G-F mice at 6-7 months. For 12 month data: WT Control n = 71 
dendrites (5 male mice), Tg2576: n = 85 dendrites (8 male mice), B6/J Control: n = 106 dendrites (7 mice, 4 males/3 females), 3xTg: n = 223 dendrites 
(14 mice, 6 males/8 females),  APPNL-G-F: n = 130 dendrites (6 mice, 3 males/6 females). For 6–7 month data: B6/J Control: n = 47 dendrites (5 female 
mice), 3xTg: n = 77 dendrites (5 male mice),  APPNL-G-F: n = 46 dendrites (7 mice, 4 males/3 females). All mice aged 12 months. *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001. WT wildtype, AUC area under Sholl curve
Page 12 of 13Bevan et al. acta neuropathol commun           (2020) 8:216 
Funding
This work was supported by the UK Dementia Research Institute which 
receives its funding from UK DRI Ltd, funded by the UK Medical Research 
Council, Alzheimer’s Society and Alzheimer’s Research UK (MC_PC_17112). 
BPM. is supported by a Programme Grant from the MRC-funded UK Dementia 
Research Institute Cardiff. PAW. is supported by the Karolinska Institutet in the 
form of a Board of Research Faculty Funded Career Position and by St. Erik Eye 
Hospital philanthropic donations, Vetenskapsrådet (2018-02124).
Data availability
The datasets used and/or analysed during the current study are available from 
the corresponding authors upon reasonable request.
Ethics approval and consent to participate
All experiments were conducted under the UK Animals Scientific Procedures 
Act 1986 and ethical guidelines at Cardiff University under the authority of UK 




The authors declare that they have no competing interests.
Author details
1 School of Optometry and Vision Sciences, Cardiff University, Cardiff CF24 
4HQ, UK. 2 UK Dementia Research Institute, Cardiff University, Cardiff, UK. 
3 Systems Immunity Research Institute, Cardiff University, Cardiff, UK. 4 Depart-
ment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, 
Karolinska Institutet, Stockholm, Sweden. 5 School of Psychology, Cardiff 
University, Cardiff, UK. 
Received: 17 November 2020   Accepted: 23 November 2020
References
 1. Baden T, Berens P, Franke K, Rosón MR, Bethge M, Euler T (2016) The func-
tional diversity of retinal ganglion cells in the mouse. Nature 529:345–
350. https ://doi.org/10.1038/natur e1646 8
 2. Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Oddo S 
(2019) Temporal and regional progression of Alzheimer’s disease-like pathol-
ogy in 3xTg-AD mice. Aging Cell 18:1–13. https ://doi.org/10.1111/acel.12873 
 3. Berry KP, Nedivi E (2017) Spine dynamics: are they all the same? Neuron 
96:43–55. https ://doi.org/10.1016/j.neuro n.2017.08.008
 4. Bittner T, Fuhrmann M, Burgold S, Ochs SM, Hoffmann N, Kretzschmar H, 
Laferla FM, Herms J (2010) Multiple events lead to dendritic spine loss in 
triple transgenic Alzheimer’s disease mice. PLoS ONE 5:1–9. https ://doi.
org/10.1371/journ al.pone.00154 77
 5. Chidlow G, Wood JPM, Manavis J, Finnie J, Casson RJ (2017) Investigations 
into retinal pathology in the early stages of a mouse model of Alzhei-
mer’s disease. J Alzheimer’s Dis 56:655–675. https ://doi.org/10.3233/JAD-
16082 3
 6. Chintapaludi S, Carter AU, Jackson H, Acklin C, Wang X, Sasner M, 
Carter G, Howell G (2020) Staging Alzheimer’s disease in the brain and 
retina of B6.APP/PS1 mice by transcriptional profiling. J Alzheimer’s Dis 
73:1421–1434. https ://doi.org/10.1101/74142 1
 7. Chiquita S, Campos EJ, Castelhano J, Ribeiro M, Sereno J, Moreira PI, 
Castelo-Branco M, Ambrósio AF (2019) Retinal thinning of inner sub-
layers is associated with cortical atrophy in a mouse model of Alzheimer’s 
disease: a longitudinal multimodal in vivo study. Alzheimer’s Res Ther 
11:1–16. https ://doi.org/10.1186/s1319 5-019-0542-8
 8. Chiquita S, Rodrigues-Neves AC, Baptista FI, Carecho R, Moreira PI, 
Castelo-Branco M, Ambrósio AF (2019) The retina as a window or mirror 
of the brain changes detected in Alzheimer’s disease: critical aspects to 
unravel. Mol Neurobiol 56:5416–5435. https ://doi.org/10.1007/s1203 
5-018-1461-6
 9. Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano 
A, Dekosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, De Haan 
W, Grundman M, Van Dyck CH, Izzo NJ, Catalano SM (2020) The clinical 
promise of biomarkers of synapse damage or loss in Alzheimer’s disease. 
Alzheimer’s Res Ther 12:1–12. https ://doi.org/10.1186/s1319 5-020-00588 
-4
 10. Gan W-BB, Grutzendler J, Wong WT, Wong RO, Lichtman JW (2000) 
Multicolor “DiOlistic” labeling of the nervous system using lipophilic 
dye combinations. Neuron 27:219–225. https ://doi.org/10.1016/S0896 
-6273(00)00031 -3
 11. Graewe B, Lemos R, Ferreira C, Santana I, Farivar R, De Weerd P, Castelo-
Branco M (2013) Impaired processing of 3D motion-defined faces in mild 
cognitive impairment and healthy aging: an fMRI study. Cereb Cortex 
23:2489–2499. https ://doi.org/10.1093/cerco r/bhs24 6
 12. Greenwood SM, Mizielinska SM, Frenguelli BG, Harvey J, Connolly CN 
(2007) Mitochondrial dysfunction and dendritic beading during neuronal 
toxicity. J Biol Chem 282:26235–26244. https ://doi.org/10.1074/jbc.M7044 
88200 
 13. Grimaldi A, Brighi C, Peruzzi G, Ragozzino D, Bonanni V, Limatola C, 
Ruocco G, Di Angelantonio S (2018) Inflammation, neurodegeneration 
and protein aggregation in the retina as ocular biomarkers for Alzhei-
mer’s disease in the 3xTg-AD mouse model. Cell Death Dis 9:1–10. https 
://doi.org/10.1038/s4141 9-018-0740-5
 14. Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade 
hypothesis. Science 256:184–185. https ://doi.org/10.1126/scien ce.15660 
67
 15. Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indica-
tors of Alzheimer’s: exploring disease in the retina. Acta Neuropathol 
132:767–787. https ://doi.org/10.1007/s0040 1-016-1613-6
 16. Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG (2014) Beta-amyloid, 
phospho-tau and alpha-synuclein deposits similar to those in the brain 
are not identified in the eyes of Alzheimer’s and Parkinson’s disease 
patients. Brain Pathol 24:25–32. https ://doi.org/10.1111/bpa.12070 
 17. Hong S, Beja-glasser VF, Nfonoyim BM, Frouin A, Ramakrishnan S, Merry 
KM, Shi Q, Rosenthal A, Barres A, Lemere CA, Selkoe DJ, Stevens B (2016) 
Complement and microglia mediate early synapse loss in alzheimer 
mouse models. Science 352:712–716
 18. Huang W, Fileta J, Guo Y, Grosskreutz CL (2006) Downregulation of Thy1 in 
retinal ganglion cells in experimental glaucoma. Curr Eye Res 31:265–271. 
https ://doi.org/10.1080/02713 68050 05456 71
 19. Hume RI, Honig MG (1986) Fluorescent carbocyanine dyes allow living 
neurons of identified origin to be studied in long-term cultures. J Cell Biol 
103:171–187
 20. Inman DM, Harun-Or-Rashid M (2017) Metabolic vulnerability in the 
neurodegenerative disease glaucoma. Front Neurosci 11:1–19. https ://
doi.org/10.3389/fnins .2017.00146 
 21. Jáñez-Escalada L, Jáñez-García L, Salobrar-García E, Santos-Mayo A, de 
Hoz R, Yubero R, Gil P, Ramírez JM (2019) Spatial analysis of thickness 
changes in ten retinal layers of Alzheimer’s disease patients based on 
optical coherence tomography. Sci Rep 9:1–14. https ://doi.org/10.1038/
s4159 8-019-49353 -0
 22. Justino L, Kergoat MJ, Bergman H, Chertkow H, Robillard A, Kergoat H 
(2001) Neuroretinal function is normal in early dementia of the Alzheimer 
type. Neurobiol Aging 22:691–695. https ://doi.org/10.1016/S0197 
-4580(01)00234 -2
 23. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, 
Schwartz M, Farkas DL (2011) Identification of amyloid plaques in retinas 
from Alzheimer’s patients and noninvasive in vivo optical imaging of 
retinal plaques in a mouse model. Neuroimage 54:S204–S217. https ://doi.
org/10.1016/j.neuro image .2010.06.020
 24. Kotimaa J, Klar-Mohammad N, Gueler F, Schilders G, Jansen A, Rutjes H, 
Daha MR, van Kooten C (2016) Sex matters: systemic complement activ-
ity of female C57BL/6J and BALB/cJ mice is limited by serum terminal 
pathway components. Mol Immunol 76:13–21. https ://doi.org/10.1016/j.
molim m.2016.06.004
 25. Lemos R, Figueiredo P, Santana I, Simões MR, Castelo-Branco M (2012) 
Temporal integration of 3D coherent motion cues defining visual objects 
of unknown orientation is impaired in amnestic mild cognitive impair-
ment and Alzheimer’s disease. J Alzheimer’s Dis 28:885–896. https ://doi.
org/10.3233/JAD-2011-11071 9
 26. Lim JKH, Li QX, He Z, Vingrys AJ, Wong VHY, Currier N, Mullen J, Bui BV, 
Nguyen CTO (2016) The eye as a biomarker for Alzheimer’s disease. Front 
Neurosci 10:1–14. https ://doi.org/10.3389/fnins .2016.00536 
Page 13 of 13Bevan et al. acta neuropathol commun           (2020) 8:216  
 27. Liu YL, Hsieh YT, Chen TF, Chiou JM, Tsai MK, Chen JH, Chen YC (2019) 
Retinal ganglion cell–inner plexiform layer thickness is nonlinearly 
associated with cognitive impairment in the community-dwelling 
elderly. Alzheimer’s Dement Diagn Assess Dis Monit 11:19–27. https ://doi.
org/10.1016/j.dadm.2018.10.006
 28. London A, Benhar I, Schwartz M (2013) The retina as a window to the 
brain: from eye research to CNS disorders. Nat Rev Neurol 9:44–53. https 
://doi.org/10.1038/nrneu rol.2012.227
 29. Mahajan D, Votruba M (2017) Can the retina be used to diagnose and 
plot the progression of Alzheimer’s disease? Acta Ophthalmol 95:768–
777. https ://doi.org/10.1111/aos.13472 
 30. Marquié M, Castilla-Martí M, Valero S, Martínez J, Sánchez D, Hernández I, 
Rosende-Roca M, Vargas L, Mauleón A, Rodríguez-Gómez O, Abdelnour 
C, Gil S, Santos-Santos MA, Alegret M, Espinosa A, Ortega G, Pérez-Cordón 
A, Sanabria Á, Roberto N, Moreno-Grau S, de Rojas I, Simó R, Ciudin A, 
Hernández C, Orellana A, Monté-Rubio G, Benaque A, Ruiz A, Tárraga L, 
Boada M (2019) Visual impairment in aging and cognitive decline: experi-
ence in a memory clinic. Sci Rep 9:1–10. https ://doi.org/10.1038/s4159 
8-019-45055 -9
 31. Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, Staurenghi 
G (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer 
thickness in Alzheimer’s disease using spectral-domain optical coherence 
tomography. Investig Ophthalmol Vis Sci 54:5953–5958. https ://doi.
org/10.1167/iovs.13-12046 
 32. Mayeux R, Stern Y (2012) Epidemiology of Alzheimer disease. Cold Spring 
Harb Perspect Med 2:1–18. https ://doi.org/10.1101/cshpe rspec t.a0062 39
 33. Morgan JL, Schubert T, Wong ROL (2008) Developmental patterning of 
glutamatergic synapses onto retinal ganglion cells. Neural Dev 3:1–19. 
https ://doi.org/10.1186/1749-8104-3-8
 34. Nunes A, Silva G, Duque C, Januário C, Santana I, Ambrósio AF, Castelo-
Branco M, Bernardes R (2019) Retinal texture biomarkers may help to 
discriminate between Alzheimer’s, Parkinson’s, and healthy controls. PLoS 
ONE 14:1–13. https ://doi.org/10.1371/journ al.pone.02188 26
 35. Poppe L, Rué L, Timmers M, Lenaerts A, Storm A, Callaerts-Vegh Z, 
Courtand G, de Boer A, Smolders S, Van Damme P, Van Den Bosch L, 
D’Hooge R, De Strooper B, Robberecht W, Lemmens R (2019) EphA4 loss 
improves social memory performance and alters dendritic spine mor-
phology without changes in amyloid pathology in a mouse model of Alz-
heimer’s disease. Alzheimers Res Ther 11:1–13. https ://doi.org/10.1186/
s1319 5-019-0554-4
 36. Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT (2016) Recent 
global trends in the prevalence and incidence of dementia, and survival 
with dementia. Alzheimer’s Res Ther 8:1–13. https ://doi.org/10.1186/
s1319 5-016-0188-8
 37. Querfurth HW, Laferla FM (2010) Alzheimer’s disease. N Engl J Med 
362:329–344. https ://doi.org/10.1056/NEJMr a0909 142
 38. Ran C, Xu X, Raymond SB, Ferrara BJ, Neal K, Bacskai BJ, Medarova Z, 
Moore A (2009) Design, synthesis, and testing of difluoroboron derivat-
ized curcumins as near infrared probes for in vivo detection of amyloid-β 
deposits. J Am Chem 131:15257–15261. https ://doi.org/10.1021/ja904 
7043
 39. Rochefort NL, Konnerth A (2012) Dendritic spines: from structure to 
in vivo function. Eur Mol Biol Organ 13:699–708. https ://doi.org/10.1038/
embor .2012.102
 40. Salobrar-García E, Rodrigues-Neves AC, Ramírez AI, de Hoz R, Fernández-
Albarral JA, López-Cuenca I, Ramírez JM, Ambrósio AF, Salazar JJ (2020) 
Microglial activation in the retina of a triple-transgenic alzheimer’s 
disease mouse model (3xTg-AD). Int J Mol Sci 21:1–15. https ://doi.
org/10.3390/ijms2 10308 16
 41. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW (2001) Changes 
in Thy1 gene expression associated with damaged retinal ganglion cells. 
Mol Vis 7:192–201
 42. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathologi-
cal alterations in Alzheimer disease. Cold Spring Harb Perspect Med 
1:1–23. https ://doi.org/10.1101/cshpe rspec t.a0061 89
 43. Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere 
CA (2017) Complement C3 deficiency protects against neurodegenera-
tion in aged plaque-rich APP/PS1 mice. Sci Transl Med 9:1–14. https ://doi.
org/10.1126/scitr anslm ed.aaf62 95
 44. Shi Q, Colodner KJ, Matousek SB, Merry K, Hong S, Kenison JE, Frost 
JL, Le KX, Li S, Dodart JC, Caldarone BJ, Stevens B, Lemere CA (2015) 
Complement C3-deficient mice fail to display age-related hippocampal 
decline. J Neurosci 35:13029–13042. https ://doi.org/10.1523/JNEUR 
OSCI.1698-15.2015
 45. Shi Z, Zheng H, Hu J, Jiang L, Cao X, Chen Y, Mei X, Li C, Shen Y (2019) 
Retinal nerve fiber layer thinning is associated with brain atrophy: a 
longitudinal study in nondemented older adults. Front Aging Neurosci 
11:1–10. https ://doi.org/10.3389/fnagi .2019.00069 
 46. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, 
Bacskai BJ, Hyman BT (2005) Dendritic spine abnormalities in amyloid 
precursor protein transgenic mice demonstrated by gene transfer and 
intravital multiphoton microscopy. J Neurosci 25:7278–7287. https ://doi.
org/10.1523/JNEUR OSCI.1879-05.2005
 47. Staffend NA, Meisel RL (2011) Diolistic labeling in fixed brain slices: phe-
notype, morphology, and dendritic spines. Curr Protoc Neurosci. https ://
doi.org/10.1002/04711 42301 .ns021 3s55
 48. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, 
Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, 
Lambris JD, Smith SJ, John SWM, Barres BA (2007) The classical comple-
ment cascade mediates CNS synapse elimination. Cell 131:1164–1178. 
https ://doi.org/10.1016/j.cell.2007.10.036
 49. De Strooper B, Karran E (2016) The cellular phase of Alzheimer’s disease. 
Cell 164:603–615. https ://doi.org/10.1016/j.cell.2015.12.056
 50. Sun W, Li N, He S (2002) Large-scale morophological survey of rat retinal 
ganglion cells. Vis Neurosci 19:483–493. https ://doi.org/10.1017/S0952 
52380 21941 07
 51. Tampellini D (2015) Synaptic activity and Alzheimer’s disease: a critical 
update. Front Neurosci 9:1–7. https ://doi.org/10.3389/fnins .2015.00423 
 52. Williams PA, Howell GR, Barbay JM, Braine CE, Sousa GL, John SWM, Mor-
gan JE (2013) Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma. 
PLoS ONE 8:1–10. https ://doi.org/10.1371/journ al.pone.00722 82
 53. Williams PA, Morgan JE, Votruba M (2010) Opa1 deficiency in a mouse 
model of dominant optic atrophy leads to retinal ganglion cell dendropa-
thy. Brain 133:2942–2951. https ://doi.org/10.1093/brain /awq21 8
 54. Williams PA, Thirgood RA, Oliphant H, Frizzati A, Littlewood E, Votruba M, 
Good MA, Williams J, Morgan JE (2013) Retinal ganglion cell dendritic 
degeneration in a mouse model of Alzheimer’s disease. Neurobiol Aging 
34:1799–1806. https ://doi.org/10.1016/j.neuro biola ging.2013.01.006
 55. Williams PA, Tribble JR, Pepper KW, Cross SD, Morgan BP, Morgan JE, 
John SWM, Howell GR (2016) Inhibition of the classical pathway of the 
complement cascade prevents early dendritic and synaptic degeneration 
in glaucoma. Mol Neurodegener 11:1–13. https ://doi.org/10.1186/s1302 
4-016-0091-6
 56. Van Wyk M, Wässle H, Taylor WR (2009) Receptive field properties of ON- 
and OFF-ganglion cells in the mouse retina. Vis Neurosci 26:297–308. 
https ://doi.org/10.1017/S0952 52380 99901 37
 57. Xu B, Sun A, He Y, Qian F, Xi S, Long D, Chen Y (2018) Loss of thin spines 
and small synapses contributes to defective hippocampal function in 
aged mice. Neurobiol Aging 71:91–104. https ://doi.org/10.1016/j.neuro 
biola ging.2018.07.010
 58. Zhang H, Wu L, Pchitskaya E, Zakharova O, Saito T, Saido T, Bezprozvanny 
I (2015) Neuronal store-operated calcium entry and mushroom spine 
loss in amyloid precursor protein knock-in mouse model of Alzheimer’s 
disease. J Neurosci 35:13275–13286. https ://doi.org/10.1523/JNEUR 
OSCI.1034-15.2015
